N278 - Semaglutida oral na doença hepática esteatótica metabólica em DM2 - Luciano Giacaglia
Autor: Luciano Giacaglia
Revista: Diabetes Obes Metab.
Ref: Arai T. Beneficial effect of oral semaglutide for type 2 diabetes mellitus in patients with metabolic dysfunction-associated steatotic liver disease: A prospective, multicentre, observational study. Diabetes Obes Metab. 2024 Nov;26(11):4958-4965. doi: 10.1111/dom.15898.
--------
3:53
N277 - Exercício de força na nefropatia diabética inicial - Samuel Brito de Almeida
Autor: Samuel Brito de Almeida
Revista: Sci Rep
Ref: Li S, Yuan S, Zhang J, Xu F, Zhu F. The effect of periodic resistance training on obese patients with type 2 diabetic nephropathy. Sci Rep. 2024 Feb 2;14(1):2761. doi: 10.1038/s41598-024-53333-4.
--------
13:11
N276 - LDL - quão baixo é seguro - Marília Izar Helfenstein Fonseca
Autor: Marília Izar Helfenstein Fonseca
Revista: Eur Heart J
Ref: Karagiannis AD. How low is safe? The frontier of very low (<30 mg/dL) LDL cholesterol. Eur Heart J. 2021 Jun 7;42(22):2154-2169. doi: 10.1093/eurheartj/ehaa1080.
Autores: Manoela Gondim
Revista: JAMA Ophthalmol
Ref: Hathaway JT. Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide. JAMA Ophthalmol. 2024 Aug 1;142(8):732-739. doi: 10.1001/jamaophthalmol.2024.2296
--------
4:39
N274 - DM e periodontite: diretrizes SOBRAPE/SBEM - Flávio Yoshikawa de Sousa
Autor: Flavio Yoshikawa de Sousa
Revista: Brazilian Journal of Periodontology
Ref: Steffens JP. Clinical management of the interrelationship between diabetes and periodontitis: joint guidelines by the Brazilian Society of Periodontology (SOBRAPE) and the Brazilian Society of Endocrinology and Metabolism (SBEM). Braz J Periodontol. 2022 Jan-Apr;32(1):90-113.
Brasil